Investigating time lags and attribution in the translation of cancer research: A case study approach

Susan Guthrie ; Alexandra Pollitt ; Stephen Hanney ; Jonathan Grant

RAND Corporation

RAND Corporation

关键词: Health Economics;    Cancer;    United Kingdom;   

DOI  :  10.7249/RR627
RP-ID  :  RR-627-WT

学科分类：自然科学（综合）

美国|英语

来源: RAND Corporation Published Research

【 摘 要 】

In 2012, RAND Europe and the Health Economics Research Group (Brunel University) were commissioned by the Wellcome Trust, Cancer Research UK, the National Institute for Health Research and the Academy of Medical Science to conduct a study of the returns to the public/charitable investment in cancer-related research. This study built on previous work published in the 2008 'What's it worth?' report that estimated the economic returns to medical research in terms of spillover benefits and health gain. The 2008 study was extensively quoted and cited as a clear justification for the economic importance of medical research and appears to have played a role in achieving the protection of the medical science budget in the recent public expenditure cuts.